Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Mar 10, 2014 sanofi Beneficial Owner (10% or more) Buy 199,822 325.34 - 332.26
Feb 11, 2014 vagelos p roy Officer Automatic Sell 11,475 325.10
Feb 11, 2014 mccorkle douglas s Officer Automatic Sell 5,819 325.00
Feb 18, 2014 aberman michael s Officer Automatic Sell 3,648 324.81 - 334.24
Feb 12, 2014 stahl neil Officer Disposition (Non Open Market) 31,936 324.44
Feb 14, 2014 sing george l Director Sell 15,000 324.00
Feb 14, 2014 aberman michael s Officer Automatic Sell 3,852 323.30
Feb 14, 2014 terifay robert j Officer Disposition (Non Open Market) 14,930 323.30
Feb 12, 2014 goldstein joseph l Director Sell 1,000 320.62
Feb 12, 2014 shooter eric m Director Sell 15,000 320.41 - 321.22
Feb 11, 2014 gilman alfred g Director Automatic Sell 5,000 320.00
Feb 12, 2014 yancopoulos george Officer Automatic Sell 88,987 317.82 - 328.50
Feb 13, 2014 stahl neil Officer Sell 22,612 316.55 - 321.17
Jul 14, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 150,000 314.52 - 319.43
Feb 11, 2014 yancopoulos george Officer Automatic Sell 100,476 314.31
Oct 1, 2013 schleifer leonard s Officer Automatic Sell 20,114 313.58
Mar 21, 2014 sanofi Beneficial Owner (10% or more) Buy 305,115 313.12 - 332.78
Oct 2, 2013 schleifer leonard s Officer Automatic Sell 9,162 312.44 - 317.34
Jul 11, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 150,000 311.39 - 318.72
Jul 7, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 256,700 311.17 - 315.59
Showing 21-40 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)